HEADER CELL CYCLE 03-NOV-14 4RQI TITLE STRUCTURE OF TRF2/RAP1 SECONDARY INTERACTION BINDING SITE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TELOMERIC REPEAT-BINDING FACTOR 2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: TRFH: RESIDUES 43-245; COMPND 5 SYNONYM: TTAGGG REPEAT-BINDING FACTOR 2, TELOMERIC DNA-BINDING COMPND 6 PROTEIN; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: TELOMERIC REPEAT-BINDING FACTOR 2-INTERACTING PROTEIN 1; COMPND 10 CHAIN: E, F, G, H; COMPND 11 FRAGMENT: YXLXP INTERACTION MOTIF: RESIDUES 89-106; COMPND 12 SYNONYM: TERF2-INTERACTING TELOMERIC PROTEIN 1, TRF2-INTERACTING COMPND 13 TELOMERIC PROTEIN 1, DOPAMINE RECEPTOR-INTERACTING PROTEIN 5, COMPND 14 REPRESSOR/ACTIVATOR PROTEIN 1 HOMOLOG, RAP1 HOMOLOG, HRAP1; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TERF2, TRBF2, TRF2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 OTHER_DETAILS: RAP1 PEPTIDE SEQUENCE KEYWDS TELOMERES, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR S.MIRON,B.GUIMARAES,G.GAULLIER,M.-J.GIRAUD-PANIS,E.GILSON,M.-H.LE DU REVDAT 4 28-FEB-24 4RQI 1 REMARK SEQADV REVDAT 3 17-JUL-19 4RQI 1 REMARK REVDAT 2 16-MAR-16 4RQI 1 JRNL REVDAT 1 10-FEB-16 4RQI 0 JRNL AUTH G.GAULLIER,S.MIRON,S.PISANO,R.BUISSON,Y.V.LE BIHAN, JRNL AUTH 2 C.TELLIER-LEBEGUE,W.MESSAOUD,P.ROBLIN,B.G.GUIMARAES,R.THAI, JRNL AUTH 3 M.J.GIRAUD-PANIS,E.GILSON,M.H.LE DU JRNL TITL A HIGHER-ORDER ENTITY FORMED BY THE FLEXIBLE ASSEMBLY OF JRNL TITL 2 RAP1 WITH TRF2. JRNL REF NUCLEIC ACIDS RES. V. 44 1962 2016 JRNL REFN ISSN 0305-1048 JRNL PMID 26748096 JRNL DOI 10.1093/NAR/GKV1531 REMARK 2 REMARK 2 RESOLUTION. 2.44 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.2_1309 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.44 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.02 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 33575 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1679 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.0286 - 5.5845 0.99 2837 149 0.1812 0.2122 REMARK 3 2 5.5845 - 4.4336 1.00 2778 146 0.1739 0.1970 REMARK 3 3 4.4336 - 3.8735 0.99 2753 145 0.1668 0.2084 REMARK 3 4 3.8735 - 3.5195 0.99 2783 147 0.1869 0.2276 REMARK 3 5 3.5195 - 3.2673 0.99 2756 145 0.2038 0.2745 REMARK 3 6 3.2673 - 3.0747 1.00 2763 145 0.2239 0.2879 REMARK 3 7 3.0747 - 2.9207 1.00 2781 146 0.2362 0.2630 REMARK 3 8 2.9207 - 2.7936 1.00 2759 146 0.2317 0.2933 REMARK 3 9 2.7936 - 2.6861 1.00 2737 144 0.2374 0.3027 REMARK 3 10 2.6861 - 2.5934 0.99 2770 146 0.2654 0.3304 REMARK 3 11 2.5934 - 2.5123 1.00 2754 145 0.2818 0.3865 REMARK 3 12 2.5123 - 2.4405 0.51 1425 75 0.3023 0.3469 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.670 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 60.59 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 70.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.18970 REMARK 3 B22 (A**2) : 3.65220 REMARK 3 B33 (A**2) : -3.46250 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 7.51970 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 7039 REMARK 3 ANGLE : 0.976 9461 REMARK 3 CHIRALITY : 0.036 1080 REMARK 3 PLANARITY : 0.004 1210 REMARK 3 DIHEDRAL : 15.250 2695 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -12.6661 1.4751 22.2870 REMARK 3 T TENSOR REMARK 3 T11: 0.3609 T22: 0.2658 REMARK 3 T33: 0.3287 T12: -0.0112 REMARK 3 T13: 0.0005 T23: 0.0543 REMARK 3 L TENSOR REMARK 3 L11: 0.3998 L22: 0.2531 REMARK 3 L33: 0.7804 L12: -0.0719 REMARK 3 L13: -0.0889 L23: 0.2114 REMARK 3 S TENSOR REMARK 3 S11: -0.0052 S12: 0.0034 S13: 0.0533 REMARK 3 S21: -0.0174 S22: -0.0124 S23: -0.0188 REMARK 3 S31: -0.0557 S32: 0.0138 S33: 0.0149 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 2 REMARK 3 NCS GROUP : 1 REMARK 3 NCS GROUP : 2 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: NULL REMARK 3 SELECTION : NULL REMARK 3 ATOM PAIRS NUMBER : NULL REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RQI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-NOV-14. REMARK 100 THE DEPOSITION ID IS D_1000087671. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : CHANNEL CUT CRYOGENICALLY COOLED REMARK 200 MONOCHROMATOR CRYSTAL REMARK 200 OPTICS : CHANNEL CUT CRYOGENICALLY COOLED REMARK 200 MONOCHROMATOR CRYSTAL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33979 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.440 REMARK 200 RESOLUTION RANGE LOW (A) : 47.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.44 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.66400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.260 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEGMME 550, HEPES BUFFER, PH 8.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 52.42500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA B 43 REMARK 465 ALA C 43 REMARK 465 GLU E 90 REMARK 465 GLU E 92A REMARK 465 ALA E 106 REMARK 465 ARG F 93A REMARK 465 ALA F 104 REMARK 465 SER F 105 REMARK 465 ALA F 106 REMARK 465 GLU G 89 REMARK 465 ASN G 90 REMARK 465 ARG G 91 REMARK 465 GLU G 92 REMARK 465 ARG G 93 REMARK 465 LEU G 94 REMARK 465 GLU H 89 REMARK 465 ASN H 90 REMARK 465 ARG H 91 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA A 43 CB REMARK 470 SER A 183 OG REMARK 470 LYS A 245 CG CD CE NZ REMARK 470 ASP B 117 CG OD1 OD2 REMARK 470 GLU B 123 CG CD OE1 OE2 REMARK 470 GLU B 125 CG CD OE1 OE2 REMARK 470 LYS B 173 CG CD CE NZ REMARK 470 LYS B 176 CG CD CE NZ REMARK 470 LYS B 179 CG CD CE NZ REMARK 470 ASP B 185 CG OD1 OD2 REMARK 470 LYS B 202 CG CD CE NZ REMARK 470 GLN B 210 CG CD OE1 NE2 REMARK 470 LYS B 242 CG CD CE NZ REMARK 470 LYS B 245 CG CD CE NZ REMARK 470 GLU C 125 CG CD OE1 OE2 REMARK 470 LYS C 173 CG CD CE NZ REMARK 470 LYS C 176 CG CD CE NZ REMARK 470 GLN C 189 CG CD OE1 NE2 REMARK 470 ASN C 197 CG OD1 ND2 REMARK 470 VAL C 208 CG1 CG2 REMARK 470 LEU C 244 CG CD1 CD2 REMARK 470 LYS C 245 CG CD CE NZ REMARK 470 GLU D 123 CG CD OE1 OE2 REMARK 470 GLU D 125 CG CD OE1 OE2 REMARK 470 LYS D 158 CG CD CE NZ REMARK 470 LYS D 176 CG CD CE NZ REMARK 470 LYS D 179 CG CD CE NZ REMARK 470 SER D 183 OG REMARK 470 LYS D 184 CG CD CE NZ REMARK 470 ASP D 185 CG OD1 OD2 REMARK 470 GLN D 189 CG CD OE1 NE2 REMARK 470 LYS D 245 CG CD CE NZ REMARK 470 ARG E 93 CG CD NE CZ NH1 NH2 REMARK 470 GLU F 90 CG CD OE1 OE2 REMARK 470 ASN F 91 CB CG OD1 ND2 REMARK 470 ARG F 92 CB CG CD NE CZ NH1 NH2 REMARK 470 LEU G 96 CG CD1 CD2 REMARK 470 GLU H 92 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU C 137 NH1 ARG C 154 1.72 REMARK 500 OE2 GLU D 137 NH1 ARG D 154 1.77 REMARK 500 OE2 GLU C 233 NZ LYS C 241 1.94 REMARK 500 OD2 ASP A 231 NZ LYS D 220 2.00 REMARK 500 O PRO C 186 N THR C 188 2.14 REMARK 500 OE2 GLU B 233 NZ LYS B 241 2.15 REMARK 500 OD1 ASP C 121 OG SER C 131 2.17 REMARK 500 NZ LYS A 140 OE2 GLU A 147 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 45 -34.88 -156.10 REMARK 500 MET A 182 -12.94 -144.82 REMARK 500 ALA B 46 -35.14 64.35 REMARK 500 MET B 122 61.97 -101.94 REMARK 500 GLU B 123 -16.05 -167.57 REMARK 500 GLU B 125 -4.56 76.24 REMARK 500 HIS B 181 -52.24 -127.94 REMARK 500 SER B 183 64.92 -69.44 REMARK 500 LYS B 184 -94.93 -88.23 REMARK 500 ASP B 185 -42.52 149.81 REMARK 500 PRO B 186 -101.16 -70.20 REMARK 500 ASP B 231 -45.76 123.46 REMARK 500 ALA C 124 20.15 -76.29 REMARK 500 SER C 183 38.47 -74.88 REMARK 500 PRO C 186 -110.51 -11.88 REMARK 500 THR C 187 -47.94 32.89 REMARK 500 GLN C 189 -35.85 -10.81 REMARK 500 ASP C 230 42.11 -69.01 REMARK 500 LYS C 242 69.32 -66.88 REMARK 500 ALA C 243 -58.43 6.77 REMARK 500 LYS D 93 -140.20 -63.65 REMARK 500 GLU D 94 145.68 66.78 REMARK 500 HIS D 95 -88.77 88.01 REMARK 500 GLU D 125 55.03 -116.78 REMARK 500 MET D 182 44.13 -106.67 REMARK 500 LYS D 184 -143.42 49.25 REMARK 500 ASP D 185 155.02 62.78 REMARK 500 THR D 187 -15.38 52.81 REMARK 500 ASP D 231 36.11 -83.23 REMARK 500 ARG E 92 -43.64 66.34 REMARK 500 ARG E 93 -52.12 -3.68 REMARK 500 ASN F 91 -115.37 -76.56 REMARK 500 ARG F 92 55.06 -161.66 REMARK 500 GLU F 93 -146.00 -76.51 REMARK 500 LEU F 94 82.00 149.18 REMARK 500 GLU F 95 -73.10 -176.41 REMARK 500 LEU F 96 165.24 99.19 REMARK 500 GLU F 97 -135.90 -76.54 REMARK 500 ALA F 98 -8.03 63.94 REMARK 500 LEU H 94 86.38 -64.34 REMARK 500 GLU H 95 147.86 -31.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG D 301 DBREF 4RQI A 43 245 UNP Q15554 TERF2_HUMAN 85 287 DBREF 4RQI B 43 245 UNP Q15554 TERF2_HUMAN 85 287 DBREF 4RQI C 43 245 UNP Q15554 TERF2_HUMAN 85 287 DBREF 4RQI D 43 245 UNP Q15554 TERF2_HUMAN 85 287 DBREF 4RQI E 90 106 UNP Q9NYB0 TE2IP_HUMAN 89 106 DBREF 4RQI F 90 106 UNP Q9NYB0 TE2IP_HUMAN 89 106 DBREF 4RQI G 89 106 UNP Q9NYB0 TE2IP_HUMAN 89 106 DBREF 4RQI H 89 106 UNP Q9NYB0 TE2IP_HUMAN 89 106 SEQADV 4RQI ASN E 91 UNP Q9NYB0 ARG 90 CONFLICT SEQADV 4RQI ARG E 92 UNP Q9NYB0 ASN 91 CONFLICT SEQADV 4RQI ASN F 91 UNP Q9NYB0 ARG 90 CONFLICT SEQADV 4RQI ARG F 92 UNP Q9NYB0 ASN 91 CONFLICT SEQADV 4RQI ASN G 90 UNP Q9NYB0 ARG 90 CONFLICT SEQADV 4RQI ARG G 91 UNP Q9NYB0 ASN 91 CONFLICT SEQADV 4RQI ASN H 90 UNP Q9NYB0 ARG 90 CONFLICT SEQADV 4RQI ARG H 91 UNP Q9NYB0 ASN 91 CONFLICT SEQRES 1 A 203 ALA GLY GLU ALA ARG LEU GLU GLU ALA VAL ASN ARG TRP SEQRES 2 A 203 VAL LEU LYS PHE TYR PHE HIS GLU ALA LEU ARG ALA PHE SEQRES 3 A 203 ARG GLY SER ARG TYR GLY ASP PHE ARG GLN ILE ARG ASP SEQRES 4 A 203 ILE MET GLN ALA LEU LEU VAL ARG PRO LEU GLY LYS GLU SEQRES 5 A 203 HIS THR VAL SER ARG LEU LEU ARG VAL MET GLN CYS LEU SEQRES 6 A 203 SER ARG ILE GLU GLU GLY GLU ASN LEU ASP CYS SER PHE SEQRES 7 A 203 ASP MET GLU ALA GLU LEU THR PRO LEU GLU SER ALA ILE SEQRES 8 A 203 ASN VAL LEU GLU MET ILE LYS THR GLU PHE THR LEU THR SEQRES 9 A 203 GLU ALA VAL VAL GLU SER SER ARG LYS LEU VAL LYS GLU SEQRES 10 A 203 ALA ALA VAL ILE ILE CYS ILE LYS ASN LYS GLU PHE GLU SEQRES 11 A 203 LYS ALA SER LYS ILE LEU LYS LYS HIS MET SER LYS ASP SEQRES 12 A 203 PRO THR THR GLN LYS LEU ARG ASN ASP LEU LEU ASN ILE SEQRES 13 A 203 ILE ARG GLU LYS ASN LEU ALA HIS PRO VAL ILE GLN ASN SEQRES 14 A 203 PHE SER TYR GLU THR PHE GLN GLN LYS MET LEU ARG PHE SEQRES 15 A 203 LEU GLU SER HIS LEU ASP ASP ALA GLU PRO TYR LEU LEU SEQRES 16 A 203 THR MET ALA LYS LYS ALA LEU LYS SEQRES 1 B 203 ALA GLY GLU ALA ARG LEU GLU GLU ALA VAL ASN ARG TRP SEQRES 2 B 203 VAL LEU LYS PHE TYR PHE HIS GLU ALA LEU ARG ALA PHE SEQRES 3 B 203 ARG GLY SER ARG TYR GLY ASP PHE ARG GLN ILE ARG ASP SEQRES 4 B 203 ILE MET GLN ALA LEU LEU VAL ARG PRO LEU GLY LYS GLU SEQRES 5 B 203 HIS THR VAL SER ARG LEU LEU ARG VAL MET GLN CYS LEU SEQRES 6 B 203 SER ARG ILE GLU GLU GLY GLU ASN LEU ASP CYS SER PHE SEQRES 7 B 203 ASP MET GLU ALA GLU LEU THR PRO LEU GLU SER ALA ILE SEQRES 8 B 203 ASN VAL LEU GLU MET ILE LYS THR GLU PHE THR LEU THR SEQRES 9 B 203 GLU ALA VAL VAL GLU SER SER ARG LYS LEU VAL LYS GLU SEQRES 10 B 203 ALA ALA VAL ILE ILE CYS ILE LYS ASN LYS GLU PHE GLU SEQRES 11 B 203 LYS ALA SER LYS ILE LEU LYS LYS HIS MET SER LYS ASP SEQRES 12 B 203 PRO THR THR GLN LYS LEU ARG ASN ASP LEU LEU ASN ILE SEQRES 13 B 203 ILE ARG GLU LYS ASN LEU ALA HIS PRO VAL ILE GLN ASN SEQRES 14 B 203 PHE SER TYR GLU THR PHE GLN GLN LYS MET LEU ARG PHE SEQRES 15 B 203 LEU GLU SER HIS LEU ASP ASP ALA GLU PRO TYR LEU LEU SEQRES 16 B 203 THR MET ALA LYS LYS ALA LEU LYS SEQRES 1 C 203 ALA GLY GLU ALA ARG LEU GLU GLU ALA VAL ASN ARG TRP SEQRES 2 C 203 VAL LEU LYS PHE TYR PHE HIS GLU ALA LEU ARG ALA PHE SEQRES 3 C 203 ARG GLY SER ARG TYR GLY ASP PHE ARG GLN ILE ARG ASP SEQRES 4 C 203 ILE MET GLN ALA LEU LEU VAL ARG PRO LEU GLY LYS GLU SEQRES 5 C 203 HIS THR VAL SER ARG LEU LEU ARG VAL MET GLN CYS LEU SEQRES 6 C 203 SER ARG ILE GLU GLU GLY GLU ASN LEU ASP CYS SER PHE SEQRES 7 C 203 ASP MET GLU ALA GLU LEU THR PRO LEU GLU SER ALA ILE SEQRES 8 C 203 ASN VAL LEU GLU MET ILE LYS THR GLU PHE THR LEU THR SEQRES 9 C 203 GLU ALA VAL VAL GLU SER SER ARG LYS LEU VAL LYS GLU SEQRES 10 C 203 ALA ALA VAL ILE ILE CYS ILE LYS ASN LYS GLU PHE GLU SEQRES 11 C 203 LYS ALA SER LYS ILE LEU LYS LYS HIS MET SER LYS ASP SEQRES 12 C 203 PRO THR THR GLN LYS LEU ARG ASN ASP LEU LEU ASN ILE SEQRES 13 C 203 ILE ARG GLU LYS ASN LEU ALA HIS PRO VAL ILE GLN ASN SEQRES 14 C 203 PHE SER TYR GLU THR PHE GLN GLN LYS MET LEU ARG PHE SEQRES 15 C 203 LEU GLU SER HIS LEU ASP ASP ALA GLU PRO TYR LEU LEU SEQRES 16 C 203 THR MET ALA LYS LYS ALA LEU LYS SEQRES 1 D 203 ALA GLY GLU ALA ARG LEU GLU GLU ALA VAL ASN ARG TRP SEQRES 2 D 203 VAL LEU LYS PHE TYR PHE HIS GLU ALA LEU ARG ALA PHE SEQRES 3 D 203 ARG GLY SER ARG TYR GLY ASP PHE ARG GLN ILE ARG ASP SEQRES 4 D 203 ILE MET GLN ALA LEU LEU VAL ARG PRO LEU GLY LYS GLU SEQRES 5 D 203 HIS THR VAL SER ARG LEU LEU ARG VAL MET GLN CYS LEU SEQRES 6 D 203 SER ARG ILE GLU GLU GLY GLU ASN LEU ASP CYS SER PHE SEQRES 7 D 203 ASP MET GLU ALA GLU LEU THR PRO LEU GLU SER ALA ILE SEQRES 8 D 203 ASN VAL LEU GLU MET ILE LYS THR GLU PHE THR LEU THR SEQRES 9 D 203 GLU ALA VAL VAL GLU SER SER ARG LYS LEU VAL LYS GLU SEQRES 10 D 203 ALA ALA VAL ILE ILE CYS ILE LYS ASN LYS GLU PHE GLU SEQRES 11 D 203 LYS ALA SER LYS ILE LEU LYS LYS HIS MET SER LYS ASP SEQRES 12 D 203 PRO THR THR GLN LYS LEU ARG ASN ASP LEU LEU ASN ILE SEQRES 13 D 203 ILE ARG GLU LYS ASN LEU ALA HIS PRO VAL ILE GLN ASN SEQRES 14 D 203 PHE SER TYR GLU THR PHE GLN GLN LYS MET LEU ARG PHE SEQRES 15 D 203 LEU GLU SER HIS LEU ASP ASP ALA GLU PRO TYR LEU LEU SEQRES 16 D 203 THR MET ALA LYS LYS ALA LEU LYS SEQRES 1 E 18 GLU ASN ARG GLU ARG LEU GLU LEU GLU ALA TYR ARG LEU SEQRES 2 E 18 GLY PRO ALA SER ALA SEQRES 1 F 18 GLU ASN ARG GLU ARG LEU GLU LEU GLU ALA TYR ARG LEU SEQRES 2 F 18 GLY PRO ALA SER ALA SEQRES 1 G 18 GLU ASN ARG GLU ARG LEU GLU LEU GLU ALA TYR ARG LEU SEQRES 2 G 18 GLY PRO ALA SER ALA SEQRES 1 H 18 GLU ASN ARG GLU ARG LEU GLU LEU GLU ALA TYR ARG LEU SEQRES 2 H 18 GLY PRO ALA SER ALA HET GOL B 301 6 HET GOL C 301 6 HET MG D 301 1 HETNAM GOL GLYCEROL HETNAM MG MAGNESIUM ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 9 GOL 2(C3 H8 O3) FORMUL 11 MG MG 2+ FORMUL 12 HOH *94(H2 O) HELIX 1 1 GLU A 45 GLY A 70 1 26 HELIX 2 2 ARG A 72 LEU A 87 1 16 HELIX 3 3 GLU A 94 GLU A 112 1 19 HELIX 4 4 THR A 127 PHE A 143 1 17 HELIX 5 5 THR A 146 ASN A 168 1 23 HELIX 6 6 GLU A 170 SER A 183 1 14 HELIX 7 7 ASP A 185 THR A 187 5 3 HELIX 8 8 THR A 188 LYS A 202 1 15 HELIX 9 9 HIS A 206 ASN A 211 1 6 HELIX 10 10 SER A 213 SER A 227 1 15 HELIX 11 11 PRO A 234 LYS A 245 1 12 HELIX 12 12 ALA B 46 GLY B 70 1 25 HELIX 13 13 ARG B 72 LEU B 87 1 16 HELIX 14 14 GLU B 94 GLU B 112 1 19 HELIX 15 15 THR B 127 PHE B 143 1 17 HELIX 16 16 THR B 146 ASN B 168 1 23 HELIX 17 17 GLU B 170 MET B 182 1 13 HELIX 18 18 THR B 188 LYS B 202 1 15 HELIX 19 19 HIS B 206 ASN B 211 1 6 HELIX 20 20 SER B 213 SER B 227 1 15 HELIX 21 21 PRO B 234 LYS B 245 1 12 HELIX 22 22 GLU C 45 GLY C 70 1 26 HELIX 23 23 ARG C 72 LEU C 87 1 16 HELIX 24 24 GLU C 94 GLU C 112 1 19 HELIX 25 25 THR C 127 PHE C 143 1 17 HELIX 26 26 THR C 146 ASN C 168 1 23 HELIX 27 27 GLU C 170 SER C 183 1 14 HELIX 28 28 THR C 188 LYS C 202 1 15 HELIX 29 29 HIS C 206 ASN C 211 1 6 HELIX 30 30 SER C 213 SER C 227 1 15 HELIX 31 31 PRO C 234 LYS C 242 1 9 HELIX 32 32 GLY D 44 GLY D 70 1 27 HELIX 33 33 ARG D 72 LEU D 87 1 16 HELIX 34 34 HIS D 95 GLU D 112 1 18 HELIX 35 35 THR D 127 PHE D 143 1 17 HELIX 36 36 THR D 146 ASN D 168 1 23 HELIX 37 37 GLU D 170 LYS D 180 1 11 HELIX 38 38 THR D 188 LYS D 202 1 15 HELIX 39 39 HIS D 206 ASN D 211 1 6 HELIX 40 40 SER D 213 SER D 227 1 15 HELIX 41 41 PRO D 234 LYS D 245 1 12 HELIX 42 42 ARG E 92 ALA E 98 1 7 HELIX 43 43 LEU H 96 ARG H 100 5 5 CISPEP 1 ALA B 124 GLU B 125 0 4.74 CISPEP 2 ASP B 230 ASP B 231 0 8.11 CISPEP 3 MET C 122 GLU C 123 0 22.97 CISPEP 4 GLU D 94 HIS D 95 0 -2.49 CISPEP 5 ASN F 91 ARG F 92 0 -2.34 SITE 1 AC1 4 HIS B 62 LEU B 65 ASP B 231 ALA B 232 SITE 1 AC2 4 ARG B 223 HIS C 62 GLU C 226 ASP C 231 SITE 1 AC3 1 GLY D 74 CRYST1 53.790 104.850 85.310 90.00 94.39 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018591 0.000000 0.001427 0.00000 SCALE2 0.000000 0.009537 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011756 0.00000